The Theranos debacle hasn't dissuaded retailers from partnering with labs. LabCorp & Walgreens Walgreens, Theranos's ex-retail partner, has moved on and entered into an agreement with another … [Read more...]
PRECISION MEDICINE
Market Trends: Lab-Retail Collaboration Remains Strong Despite Theranos Debacle
January 21, 2019
MARKETING
Genetic Testing: 23andMe Gets FDA Clearance for Direct-to-Consumer Marketing of Personal Genome Service
January 14, 2019
The FDA is allowing direct-to-consumer marketing, with special controls, of the 23andMe Personal Genome Service Pharmacogenetic Reports test for genetic variants to detect 33 variants for multiple … [Read more...]
DISTRIBUTION AGREEMENTS
Diagnostic Deals: A Roundup of the Key Mergers, Acquisitions, Alliances, Licenses and Other Strategic Transactions From the Past Month
December 17, 2018
As the year winds down, diagnostic deals aren't as plentiful. Nevertheless, there have been some significant transactions. Here's a recap of the key activity from mid-October through the third week of … [Read more...]
MARKETING
Industry Trends: Continued Momentum for Lab-Retail Collaboration
December 14, 2018
The Theranos debacle hasn't dissuaded retailers from partnering with labs. Here's a rundown of some recent deals. LabCorp & Walgreens In fact, Walgreens, Theranos's ex-retail partner, has moved … [Read more...]
MARKETING
Dealing with Consumers: Using Patient Online Reviews to Boost Your Lab Business
December 10, 2018
Patients are making increasing use of physician rating and review sites to comment on their medical experiences the way diners do with restaurants. And as with restaurants, this can be a tremendous … [Read more...]
INNOVATION
LDTs: FDA Approves First NGS Residual Cancer Detection Test
December 10, 2018
The FDA broke new ground by allowing marketing of Adaptive Biotechnologies' ClonoSEQ assay, a next generation sequencing (NGS)-based test for minimal residual disease (MRD) in patients with acute … [Read more...]
PARTNERSHIPS
Diagnostic Deals: A Roundup of the Key Mergers, Acquisitions, Alliances, Licenses and Other Strategic Transactions From the Past Month
November 12, 2018
The swirl of autumn leaves has brought a swirl of diagnostic deals. Here's a recap of the key activity from mid-September through the third week of October. M&A and Asset Sales Quest Diagnostics … [Read more...]
CUSTOMER SERVICE
Lab Leaders Have New Opportunities in the Age of Consumerism
October 30, 2018
The G2 Power Panel provided attendees at the 36th annual Lab Institute (Oct. 24-26; Washington, D.C.) an opportunity to learn how some of the nation's leading laboratories are navigating the current … [Read more...]
OUTREACH ASSETS
Attendees Given Insider’s Look at a Hospital Laboratory Joint Venture
October 30, 2018
Hospital systems are increasingly exploring joint ventures as a means to monetize some of the hospital outreach laboratory's assets without exiting the business. Attendees at G2's 36th annual … [Read more...]
ACQUISITIONS
Diagnostic Deals: A Roundup of the Key Mergers, Acquisitions, Alliances, Licenses and Other Strategic Transactions From the Past Month
October 15, 2018
Amid back to school season, companies were back to making diagnostic deals. Here's a recap of the key activity from mid-August through the third week of September. M&A and Asset Sales This … [Read more...]
